tranScrip Partners LLP Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2008

Location

Primary Industry

Pharmaceuticals

About

Based in the UK and founded in 2008, tranScrip Partners LLP provides drug development services for the development and lifecycle activities of biopharmaceutical companies. The company offers services such as translational medicine, medical affairs, and advanced therapeutics research. The company works with its multi-functional teams to provide in-depth therapeutic, strategic, and operational expertise in areas such as translational medicine, rare diseases, and pharmaceutical portfolio management.

Current Investors

Palatine

Request a demo to show more

Primary Industry

Pharmaceuticals

Sub Industries

Pharmaceutical Research & Development

Website

www.transcrip-partners.com

Company Stage

Mature - Buyout

Total Amount Raised

Subscriber access only

Deals

Deals Type
Add-on
Buyout

Deal Status	Target (s)	Deal Date	Investor(s)	Seller(s)	Deal size (Mn)	Enterprise value (Mn)	Post-money valuation (Mn)	EBITDA multiple (x)	Revenue multiple (x)	Lead partner (s)
Completed	Real Regulatory Ltd	28 Mar 2022
Completed	tranScrip Partners LLP	27 Jan 2021

Displaying 1-2 of 2

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.